Aquaretic effects of niravoline, a chi-opioid agonist, in patients with cirrhosis

MLA

Gadano, A., et al. “Aquaretic Effects of Niravoline, a Chi-Opioid Agonist, in Patients with Cirrhosis.” Journal of Hepatology, vol. 32, no. 1, Jan. 2000, pp. 38–42. EBSCOhost, https://doi.org/10.1016/S0168-8278(00)80187-7.

APA

Gadano, A., Moreau, R., Pessione, F., Trombino, C., Giuily, N., Sinnassamy, P., Valla, D., & Lebrec, D. (2000). Aquaretic effects of niravoline, a chi-opioid agonist, in patients with cirrhosis. Journal of Hepatology, 32(1), 38–42. https://doi.org/10.1016/S0168-8278(00)80187-7

Chicago

Gadano, A., R. Moreau, F. Pessione, C. Trombino, N. Giuily, P. Sinnassamy, D. Valla, and D. Lebrec. 2000. “Aquaretic Effects of Niravoline, a Chi-Opioid Agonist, in Patients with Cirrhosis.” Journal of Hepatology 32 (1): 38–42. doi:10.1016/S0168-8278(00)80187-7.